CYPHERPUNK TECHNOLOGIES INC. Earnings Per Share, Basic and Diluted
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Earnings Per Share, Basic and Diluted of -$0.14 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-11-12
- CYPHERPUNK TECHNOLOGIES INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.14.
- CYPHERPUNK TECHNOLOGIES INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.12.
- CYPHERPUNK TECHNOLOGIES INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.12.
- CYPHERPUNK TECHNOLOGIES INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.09.
- CYPHERPUNK TECHNOLOGIES INC. earnings per share, basic and diluted for fiscal 2020 was -$0.63.
- CYPHERPUNK TECHNOLOGIES INC. earnings per share, basic and diluted for fiscal 2019 was -$1.47.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$0.14 10-Q · filed 2021-11-12 | -$0.27 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.39 10-Q · filed 2021-11-12 | -$0.47 derived: net income ÷ weighted average shares · filed 2022-11-14 |
| 2021-06-30 | -$0.12 10-Q · filed 2021-08-13 | -$0.24 10-Q · filed 2021-08-13 | -$0.33 derived: net income ÷ weighted average shares · filed 2022-08-12 | -$0.42 derived: net income ÷ weighted average shares · filed 2022-08-12 |
| 2021-03-31 | -$0.12 10-Q · filed 2021-05-14 | -$0.21 derived: net income ÷ weighted average shares · filed 2022-05-13 | -$0.30 derived: net income ÷ weighted average shares · filed 2022-05-13 | -$0.42 derived: net income ÷ weighted average shares · filed 2022-05-13 |
| 2020-12-31 | -$0.09 derived: net income ÷ weighted average shares · filed 2022-03-11 | -$0.18 derived: net income ÷ weighted average shares · filed 2022-03-11 | -$0.30 derived: net income ÷ weighted average shares · filed 2022-03-11 | -$0.63 10-K · filed 2021-03-12 |
| 2020-09-30 | -$0.09 10-Q · filed 2021-11-12 | -$0.21 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.58 10-Q · filed 2021-11-12 | -$0.84 derived: net income ÷ weighted average shares · filed 2021-11-12 |
| 2020-06-30 | -$0.12 10-Q · filed 2021-08-13 | -$0.57 10-Q · filed 2021-08-13 | -$0.88 derived: net income ÷ weighted average shares · filed 2021-08-13 | -$1.20 derived: net income ÷ weighted average shares · filed 2021-08-13 |
| 2020-03-31 | -$0.55 10-Q · filed 2021-05-14 | -$0.91 derived: net income ÷ weighted average shares · filed 2021-05-14 | -$1.25 derived: net income ÷ weighted average shares · filed 2021-05-14 | -$1.62 derived: net income ÷ weighted average shares · filed 2021-05-14 |
| 2019-12-31 | -$0.33 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$0.66 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$1.03 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$1.47 10-K · filed 2021-03-12 |
| 2019-09-30 | -$0.33 10-Q · filed 2020-11-12 | -$0.70 derived: net income ÷ weighted average shares · filed 2020-11-12 | -$1.15 10-Q · filed 2020-11-12 | |
| 2019-06-30 | -$0.37 10-Q · filed 2020-08-13 | -$0.82 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | -$0.47 10-Q · filed 2020-05-14 | |||
| 2018-09-30 | -$0.45 10-Q · filed 2018-11-09 | -$0.95 derived: net income ÷ weighted average shares · filed 2019-11-14 | -$1.76 10-Q · filed 2018-11-09 | |
| 2018-06-30 | -$0.50 10-Q · filed 2019-08-09 | -$1.32 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | -$0.85 10-Q · filed 2019-05-15 | |||
| 2017-09-30 | -$0.73 10-Q · filed 2018-11-09 | -$1.46 derived: net income ÷ weighted average shares · filed 2018-11-09 | -$2.72 10-Q · filed 2018-11-09 | |
| 2017-06-30 | -$0.74 10-Q · filed 2018-08-08 | -$2.03 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | -$1.39 10-Q/A · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |